Every hour mattered. The package was opened in a specialised biocontainment lab.
Institut Pasteur de Dakar sequenced hantavirus genome from Cape Verde cruise ship passengers in under 24 hours, enabling rapid WHO response and contact tracing protocols. The lab is part of a global Pasteur Network supporting 20+ countries during COVID-19 and responding to Marburg and Ebola outbreaks across sub-Saharan Africa.
- Institut Pasteur de Dakar sequenced hantavirus genome within 24 hours on May 5-6, 2026
- MV Hondius cruise ship carried 150 people from 23 countries; three passengers died
- Identified as Andes hantavirus strain, known to spread through close human contact
- Lab supported 20+ countries during COVID-19 and has responded to Marburg and Ebola outbreaks
- U.S. NIH recently ended funding for Centers for Research in Emerging Infectious Diseases Network
Senegal's Institut Pasteur de Dakar rapidly identified Andes hantavirus strain aboard a stranded cruise ship within 24 hours, demonstrating the vital importance of distributed global laboratory networks for outbreak containment.
On the morning of May 5, a plane touched down in Senegal carrying something urgent: biological samples from a cruise ship stranded off Cape Verde, where passengers were falling ill with a virus that kills roughly one in three people it infects. The World Health Organization needed answers fast. Could the Institut Pasteur de Dakar—a research center an hour's flight from the stricken vessel—help identify what was spreading through the ship's cabins?
The scientists in Dakar didn't sleep that night. By 3 a.m., the triple-sealed package of specimens was opened in a specialized biocontainment facility. Trained technicians deactivated the samples and prepared them for analysis. The sequencing machines hummed through the darkness, mapping the virus's genetic code. Within 24 hours, they had their answer: Andes hantavirus, a strain known to spread through close human contact. Laboratories in South Africa and Switzerland reached the same conclusion that same day. The WHO announced the findings at a press conference, and the world had clarity on what it was facing.
The speed mattered enormously. The MV Hondius, an expedition cruise ship, had carried roughly 150 people from 23 countries. It had stopped at remote Atlantic islands. Three passengers had already died, including one who had transited through Johannesburg. Every hour of delay meant more potential exposure, more uncertainty about how to contain what came next. Dr. Moussa Moise Diagne, the virologist heading the sequencing platform at Institut Pasteur de Dakar, understood the stakes. "It's crucial to have, in different parts of the world, the capacity and capabilities to detect those different pathogens," he said. The identification wasn't just academic—it shaped how health officials would manage cases, trace contacts, and prevent further spread.
By May 8, the full genome had been sequenced and compared against known strains. Laboratories worldwide examined the data for mutations that might change how aggressively the virus could spread. The good news: no significant mutations emerged compared to the 2018–19 outbreak in Argentina. But questions remained. Where had the first infections occurred? When? The virus has an incubation period stretching up to six weeks, meaning cases could still emerge globally. "The most important thing now is to know what is the window of exposure in Latin America," Diagne said, pointing to the detective work still ahead.
The Institut Pasteur de Dakar is not a household name, but it is a linchpin in global disease surveillance. It is part of the Pasteur Network alliance and supported roughly 20 countries during the COVID-19 pandemic. It has responded to Marburg in Guinea and Ebola in the Democratic Republic of Congo. It developed rapid tests for current outbreaks. It is, in other words, exactly the kind of distributed laboratory capacity that the world needs when pathogens emerge in unexpected places.
Yet this capability is now under threat. The Institut Pasteur and similar networks have recently lost funding for pandemic prevention work. The U.S. National Institutes of Health ended support for the Centers for Research in Emerging Infectious Diseases Network, a global initiative that includes a West African center. A pilot project studying how hantavirus infects humans was also cancelled. The U.S. Department of Health and Human Services said it remains committed to global health security, insisting that suggestions of American retreat "do not reflect the reality of our ongoing engagement and support internationally." But the funding cuts are real, and they come at a moment when the hantavirus outbreak—followed swiftly by a fast-spreading Ebola emergency in central Africa—has made the value of these networks unmistakably clear. The question now is whether governments will sustain the infrastructure that proved itself in those 24 hours off Cape Verde, or whether the next outbreak will find the world less prepared.
Notable Quotes
It's crucial to have, in different parts of the world, the capacity and capabilities to detect those different pathogens. It's really important for clinical case management and contact tracing.— Dr. Moussa Moise Diagne, virologist and head of sequencing platform at Institut Pasteur de Dakar
The most important thing now is to know what is the window of exposure in Latin America.— Dr. Moussa Moise Diagne
The Hearth Conversation Another angle on the story
Why did it matter so much that Senegal's lab got the answer in 24 hours instead of, say, a week?
Because hantavirus spreads through close contact. Every day of uncertainty meant health officials couldn't tell people who was actually at risk. Contact tracing—finding everyone who'd been near an infected person—becomes guesswork without knowing what you're looking for. And with 150 people from 23 countries on that ship, the clock was ticking.
The lab worked through the night. Was this unusual, or is that just how outbreak response works?
It's both. Outbreak response is always urgent, but this was extreme because the WHO had chartered a plane specifically to get samples there. The whole world was watching. These scientists knew their work would shape how governments responded within hours of the results being released.
You mentioned the lab had supported 20 countries during COVID. How does a single lab in Senegal build that kind of capacity?
It's part of a network—the Pasteur Network—that shares resources, expertise, and equipment across borders. But it also requires sustained funding and political commitment. The lab invested in sophisticated sequencing machines and trained staff who could work in biocontainment facilities. That doesn't happen by accident.
And now that funding is being cut?
Yes. The U.S. ended support for the very networks that just proved their worth. A pilot project on hantavirus itself was cancelled. The irony is sharp—we just watched this lab save lives, and simultaneously, the money to keep it running at this level is disappearing.
What happens if the next outbreak hits and the lab isn't as well-equipped?
You get delays. You get uncertainty. You get health officials making decisions without the genetic data they need. And with a virus that can incubate for six weeks, every day of delay means more potential spread before anyone even knows there's a problem.